At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Jun 3, 2026 at 08:18 ET
NRx Pharmaceuticals priced an underwritten public offering of 5,714,286 shares at $3.50/share, with gross proceeds of ~$20.0M ($23.0M if underwriters fully exercise the 30-day option). The offering is dilutive (~11% of pre-offering shares) and proceeds are for working capital and general corporate purposes. The stock closed at $3.50 on June 3, 2026, indicating no premium/discount at pricing.
- Pricing of 5,714,286 shares at $3.50 per share
- Gross proceeds of approximately $20.0 million ($23.0 million if option exercised)
- Underwriters granted 30-day option to purchase up to 857,142 additional shares
- Offering expected to close June 4, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access